Centers | ||
|
|
|
EU-OPENSCREEN | University of Pittsburgh Chemical Diversity Center (UPCDC) | Center for Drug Discovery |
EU-OPENSCREEN is a multinational, not-for-profit initiative, which
integrates high-capacity screening platforms and chemistry groups across
Europe. The aim of this initiative is to support individual scientists
interested in chemical biology... |
The University of Pittsburgh Chemical Diversity Center (UPCDC) is a member of the NCI Chemical Biology Consortium (CBC). Our Center was established in 2008 and built on the foundation of the University of Pittsburgh Center for Chemical Methodologies... |
Projects
-... Read more |
Partnerships |
Events |
Jobs |
XenoTech / XenoGesis
View all Evotec and Yale University to collaborate on cancer therapyEvotec announced a research collaboration, TargetDBR (DNA Break Repair), with the laboratories of Prof. Peter Glazer and Prof. Ranjit Bindra at Yale School of Medicine. The objective of this collaboration is to identify novel mechanisms, targets and... View all Eisiai Partners with Johns Hopkins Brain Science InstituteEisiai Partners with Johns Hopkins Brain Science Institute ("BSi") an institute which is part of Johns Hopkins University to develop new drugs for neurological diseases. Under this joint collaboration, BSi will provide validated targets to Eisai... View all |
In this "Things You Need to Know" series on emerging technologies, we will learn from prominent...  |
Assistant Director - ICCB-Longwood Screening Facility
... 06 April, 2022 Learn More Postdoc
id: 22536 T32 Postdoctoral Fellow position in microbiome and gut-brain axis research
id: 22537 Postdoctoral Associate -Laboratory of Immune Cell Epigenetics and Signaling
id: 22538 |
